Price, purchase channel introduction and risk warning of the Indian version of Quizartinib

Quizartinib is a targeted drug used to treat acute myeloid leukemia (AML). It has a significant effect on patients with FLT3 mutations. Since Quizartinib has not yet been approved for marketing in my country, domestic patients need to purchase the drug through overseas channels. It should be noted that there is currently no Indian generic version of Quizartinib on the market, so low-priced generic versions of this drug are not available in the Indian market.

In overseas markets, quizartinib mainly has original research versions and some lower-priced generic versions. What has attracted more attention is the generic drug produced by Lucius Pharmaceutical Factory in Laos. This version mainly has two specifications: 17.7mg14 tablets and 26.5mg14 tablets. The price is relatively affordable, about more than 1,000 yuan per box. Although this generic version is low-priced, according to public information, its drug ingredients are basically the same as the original version, making it an economical and affordable option for many patients.

In terms of purchase channels, since Quizartinib is not available in China, patients generally need to purchase it through regular overseas drug agents, medical tourism agencies or authorized international drug procurement platforms. It is very important to choose formal channels to ensure the authenticity, quality and safety of medicines. Patients should provide a doctor's prescription and relevant medical certificates when purchasing, and avoid purchasing drugs illegally to avoid buying fake drugs or inferior products.

Finally, patients need to be aware of the risks when choosing to purchase drugs overseas. Purchasing drugs overseas involves transportation, customs clearance, storage, etc., and there may be risks of delays or damage to the drugs. In addition, cross-border drug purchases lack domestic legal protection. Once there are problems with drug quality or efficacy, it is difficult to protect rights. It is recommended that patients weigh the price and safety of drugs under the guidance of professional doctors, choose the most suitable treatment plan, and do not buy blindly to ensure drug safety and therapeutic effect.

Reference materials:https://www.drugs.com/